1. Home
  2. ROL vs DXCM Comparison

ROL vs DXCM Comparison

Compare ROL & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rollins Inc.

ROL

Rollins Inc.

N/A

Current Price

$53.38

Market Cap

26.5B

Sector

Finance

ML Signal

N/A

Logo DexCom Inc.

DXCM

DexCom Inc.

N/A

Current Price

$66.41

Market Cap

26.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROL
DXCM
Founded
1948
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.5B
26.5B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
ROL
DXCM
Price
$53.38
$66.41
Analyst Decision
Buy
Strong Buy
Analyst Count
10
21
Target Price
$66.10
$85.33
AVG Volume (30 Days)
2.5M
3.3M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
1.37%
N/A
EPS Growth
13.54
47.18
EPS
1.09
2.09
Revenue
$2,161,220,000.00
N/A
Revenue This Year
$10.42
$14.48
Revenue Next Year
$8.81
$12.39
P/E Ratio
$48.78
$32.04
Revenue Growth
7.23
N/A
52 Week Low
$51.77
$54.11
52 Week High
$66.14
$89.07

Technical Indicators

Market Signals
Indicator
ROL
DXCM
Relative Strength Index (RSI) 28.25 40.88
Support Level N/A $63.72
Resistance Level $58.38 $69.38
Average True Range (ATR) 1.24 1.87
MACD -0.27 -0.18
Stochastic Oscillator 10.13 29.64

Price Performance

Historical Comparison
ROL
DXCM

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: